Earnings Release Notice
PAI summary · Not investment advice
Pharma Research plans to disclose its Q3 2026 consolidated results on November 6, 2026.
Commentary
AI commentary · Not investment advice
What happened
Pharma Research gave advance notice that it will disclose its third-quarter 2026 earnings. The notice was filed on October 28, 2026, and the actual earnings disclosure is scheduled for November 6, 2026.
In the company's terms
The period covered runs from January 1, 2026 to September 30, 2026. The figures will be reported on a K-IFRS consolidated basis for the third quarter of 2026. This advance notice does not include specific figures such as revenue or operating profit, nor any comparison with prior periods.
What changes for shareholders
For shareholders, the date to note is November 6, 2026, when the consolidated results are scheduled to be disclosed. The detailed figures will be available in that filing.
Show Korean comments
Comments
No comments yet
Comments from shareholders will appear here.
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist